Changchun, China

Yongqing Guo

This inventor holds 1 USPTO granted patent. Top assignees: Changchun Bcht Biotechnology Co., Jilin University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongqing Guo. Retrieved from https://idiyas.com/inventor/yongqing-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yongqing Guo: Innovator in Vaccine Development

Introduction

Yongqing Guo is a prominent inventor based in Changchun, China. He has made significant contributions to the field of biotechnology, particularly in vaccine development. His innovative work focuses on addressing tauopathies, including Alzheimer's disease.

Latest Patents

Yongqing Guo holds a patent for a phosphorylated polypeptide antigen vaccine. This invention includes at least two polypeptide fragments or conservatively modified variants derived from the human full-length Tau protein. The polypeptide fragments contain phosphorylation sites, which are crucial for the vaccine's effectiveness. Additionally, the patent describes a complex vaccine formed by coupling the phosphorylated polypeptide antigen vaccine with a carrier. This vaccine can be utilized for preventing and treating tauopathies, including Alzheimer's disease.

Career Highlights

Throughout his career, Yongqing Guo has worked with notable organizations such as Changchun Bcht Biotechnology Co. and Jilin University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Yongqing Guo has collaborated with several professionals in his field, including Wei Kong and Hui Wu. These partnerships have enhanced his research efforts and fostered innovation in vaccine development.

Conclusion

Yongqing Guo's work in developing a phosphorylated polypeptide antigen vaccine represents a significant advancement in the fight against tauopathies. His contributions to biotechnology continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…